CClinicalTrials.gg
CompletedNCT00935779Updated Jul 9, 2009

Ultra Structure Of Peritoneum At Electronic Microscopy In Control Subjects And Patients With Gastric Cancer

An observational study in Stomach Neoplasm, sponsored by University of Chile. Completed at 1 site in Chile. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2009-07-09.

Sponsored by University of Chile · Observational

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
18
Ages
18 Years and older
Sex
All
01

Study summary

Peritoneal metastases appear in a great proportion of patients affected by gastric carcinoma. Involved mechanisms are poorly understood though experimentally it has been demonstrated that neoplastic cells exfoliated from primary tumor can only implant and proliferate in areas of damaged peritoneum. Objectives: to study ultra-structure of peritoneal surface by electronic microscopy in control subjects and in patients with early or locally advanced gastric cancer looking for spontaneous changes in peritoneal surface not related with surgical injury.

Read the detailed description

18 out of 32 cases were eligible for analysis. Four patients operated on for benign diseases served as control and 14 patients with operable local gastric adenocarcinoma (4 mucosa/submucosa/muscular y 10 serosa lesions) were studied. At the beginning of surgery, a 2 x 2 cm. sample from macroscopically normal visceral peritoneum at mesenterium root was carefully obtained, washed with saline and fixed in glutaraldehyde solution. Besides a sample of peritoneal washing fluid was studied to exclude patients with free cancer cells. Peritoneal tissue was fixed during 24 hours and then all samples were evaluated by electronic microscope.

02

Conditions studied

  • Stomach Neoplasm

Browse trials for

Keywords

  • Stomach Neoplasms
  • Peritoneum
03

In context

Stomach Neoplasms

2,850 studies on the registry are indexed under Stomach Neoplasms; 863 are open to participants now.

This study's enrollment of 18 is below the median of 274 across 670 observational studies indexed under Stomach Neoplasms.

Browse Stomach Neoplasms studies →

Lead sponsor

University of Chile is the lead sponsor of 191 studies on the registry; 36 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

patients with operable local gastric adenocarcinoma consulting to Hospital Clinico, University of Chile during study period.

Inclusion criteria

  • patients with operable local gastric adenocarcinoma

Exclusion criteria

Exclusion Criteria:

  • previous abdominal surgery
  • previous open or blunt abdominal trauma
  • history of inflammatory bowel disease or Typhoid Fever, Gallstone disease, chemotherapy or radiotherapy, or any other abdominal condition that could alter peritoneal integrity.
  • All other gastric malignancies such as lymphomas, GIST, carcinoids
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
18 participants (actual)

Groups and cohorts

  • Gastric cancer

    patients with operable local gastric adenocarcinoma were studied

  • Control group

    patients operated on for benign diseases served as controls, randomly selected among patients with chronic gastro-esophageal reflux disease who were considered good candidates for antireflux surgery and properly matched in sex and age to study group

06

Study locations

1 site
  • Department of Surgery, Clinical Hospital, University of Chile
    Santiago, Region Metropolitana, Chile
07

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 9, 2009, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT00935779
Lead sponsor
University of Chile
First posted
Jul 9, 2009
Start date
Oct 2002
Primary completion
Jul 2004
Completion
Dec 2004
Last update
Jul 9, 2009

Study contacts

Patricio Burdiles, MD
principal investigator · Department of Surgery, Clinical Hospital, University of Chile

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2009. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion